Life-saving medical equipment and solutions provider OxygenCare has today announced a new partnership with US firm Defibtech, which makes life-saving resuscitation devices.
The deal will improve the availability of rescue-ready defibrillators in Ireland which could save lives.
OxygenCare has extensive experience in the Irish healthcare industry and said the addition of Defibtech's Lifeline AED (automated external defibrillators) will enhance its existing portfolio.
Cardiovascular disease is a leading cause of death in Ireland, with at least 9,000 deaths and 25,000 hospital admissions each year according to the HSE.
The availability of functional defibrillators is crucial, and inadequate maintenance has rendered many devices non-functional, exacerbating the issue.
Conrad Wynne, Senior Product Specialist, Resuscitation at OxygenCare, said the partnership with Defibtech not only enhances the company's critical care offering but enables it to help ensure that AEDs across Ireland are both available and functional when people need them.
"Emergency situations arise all the time and every second counts in these situations, so having operational, life-saving technology is crucial," he added.
Joseph Mullally, Senior Vice President of Commercial Operations at Defibtech, said that partnering with an industry leader like OxygenCare was a natural fit for Defibtech.
"We have a shared mission to provide emergency medical technology and spread awareness which can save lives. We recognise that the true impact of our work lies not only in the accessibility of our products but also through knowledge and skills," he stated.
